Thomas C. Smyrk

country of citizenship: United States of America

educated at: University of Minnesota Medical School, University of Minnesota

occupation: researcher, pathologist

Series

There is nothing here

Create a new serie

Works

There is nothing here

Create a new work

Articles 366

Date

Title

Authors

2021-05-03

DNA Methylation Markers for Detection of Cholangiocarcinoma: Discovery, Validation, and Clinical Testing in Biliary Brushings and Plasma

Ju Dong Yang, Lewis R. Roberts, John B Kisiel, Thomas C. Smyrk
2020-04-05

Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer

Frank A Sinicrope, Fabienne Hermitte, Bernhard Mlecnik, Richard M Goldberg, Anthony F Shields, Steven R Alberts, Jérôme Galon, Thomas C. Smyrk
2020-06-15

Accurate Nonendoscopic Detection of Barrett's Esophagus by Methylated DNA Markers: A Multisite Case Control Study

David A. Ahlquist, Thomas C. Smyrk
2020-05-22

Pancreatic ductal adenocarcinoma is associated with a unique endocrinopathy distinct from type 2 diabetes mellitus

Thomas C. Smyrk
2020-07-14

Targeting of the Hedgehog/GLI and mTOR pathways in advanced pancreatic cancer, a phase 1 trial of Vismodegib and Sirolimus combination

Alex A Adjei, Charles Erlichman, Val J. Lowe, Tanios Bekaii-Saab, Thomas C. Smyrk, G. Kim Bigley, Mitesh J Borad, Angela L McCleary-Wheeler, Jacob B Allred, Luciana L Almada, Martín E Fernández-Zapico
2020-02-26

Clinical Outcomes in Patients With Colon Cancer With Microsatellite Instability of Sporadic or Familial Origin Treated With Adjuvant FOLFOX With or Without Cetuximab: A Pooled Analysis of the PETACC8 and N0147 Trials

Steven R Alberts, Thomas C. Smyrk
2020-09-18

Methylated DNA markers of esophageal squamous cancer and dysplasia: an international study

Yi Qin, William Bamlet, Seth W Slettedahl, Reza Malekzadeh, Christian C. Abnet, David Katzka, Mark D Topazian, Sanford M Dawsey, John B Kisiel, David A. Ahlquist, Thomas C. Smyrk
2020-10-05

The Novel Form of Amyloidosis Derived From EGF-Containing Fibulin-Like Extracellular Matrix Protein 1 (EFEMP1) Preferentially Affects the Lower Gastrointestinal Tract of Elderly Females

Linda N Dao, Angela Dispenzieri, Thomas C. Smyrk
2020-12-17

Prognostic variables in low and high risk stage III colon cancers treated in two adjuvant chemotherapy trials

Gunnar Folprecht, Steven R Alberts, Thomas C. Smyrk
2020-12-18

A Broad-Based Submucosal Polyp

Thomas C. Smyrk
2020-12-22

Novel methylated DNA markers accurately discriminate Lynch syndrome associated colorectal neoplasia

Veroushka Ballester, Seth W Slettedahl, Tracy C Yab, Frank A Sinicrope, Clement Richard Boland, Thomas C. Smyrk, Lisa A Boardman, John B Kisiel, David A. Ahlquist
2019-09-16

Discovery, Validation, and Application of Novel Methylated DNA Markers for Detection of Esophageal Cancer in Plasma

Yi Qin, John B Kisiel, David A. Ahlquist, Thomas C. Smyrk
2019-04-01

Cyclooxygenase-2 and Cytosolic Phospholipase A2 Are Overexpressed in Mucinous Pancreatic Cysts

Thomas C. Smyrk
2019-10-01

Biliary Amyloidoma as a Cause for Pancreatitis

Yi Qin, Thomas C. Smyrk
2019-02-05

Hepatocellular Carcinoma Detection by Plasma Methylated DNA: Discovery, Phase I Pilot, and Phase II Clinical Validation

David A. Ahlquist, Thomas C. Smyrk
2019-11-21

Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer

Paul Haluska, Henry C Pitot, Charles Erlichman, Julian R Molina, Val J. Lowe, Tanios Bekaii-Saab, Thomas C. Smyrk, Wilma L Lingle, Aminah Jatoi, Scott H Okuno, Axel Grothey, G. Kim Bigley, Mitesh J Borad, Donald W Northfelt, Angela L McCleary-Wheeler, Jacob B Allred, Luciana L Almada, Martín E Fernández-Zapico
2019-09-01

Novel Methylated DNA Markers Discriminate Advanced Neoplasia in Pancreatic Cysts: Marker Discovery, Tissue Validation, and Cyst Fluid Testing

David A. Ahlquist, Thomas C. Smyrk
2019-05-29

Idiopathic myointimal hyperplasia is a distinct cause of chronic colon ischaemia

Rondell P Graham, Thomas C. Smyrk
2019-07-16

Methylated DNA in Pancreatic Juice Distinguishes Patients With Pancreatic Cancer From Controls

Massimo Raimondo, Gloria M Petersen, David A. Ahlquist, Thomas C. Smyrk
2019-07-01

Albumin In Situ Hybridization Can Be Positive in Adenocarcinomas and Other Tumors From Diverse Sites

Rondell P Graham, Thomas C. Smyrk
2019-08-26

Survival benefit of neoadjuvant therapy in patients with non-metastatic pancreatic ductal adenocarcinoma: A propensity matching and intention-to-treat analysis

Motokazu Sugimoto, Thomas C. Smyrk
2019-04-01

Solid Pseudopapillary Neoplasms of the Pancreas: A Large American Cohort

Zhaohui Jin, Amit Mahipal, Steven R Alberts, Thomas C. Smyrk
2019-03-01

High-Grade Dysplasia in Resected Main-Duct Intraductal Papillary Mucinous Neoplasm (MD-IPMN) is Associated with an Increased Risk of Subsequent Pancreatic Cancer

Thomas C. Smyrk
2019-04

Staging of T1 esophageal adenocarcinoma with volumetric laser endomicroscopy: a feasibility study

Thomas C. Smyrk, Lori S Lutzke, Cadman L Leggett
2019-01-24

A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance)

Thomas C. Smyrk, Steven R Alberts
2018-04-19

Outcome of Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Mayo Clinic Experience

Zhaohui Jin, Joleen M Hubbard, Thomas C. Smyrk
2018-04-30

Fasting Blood Glucose Levels Provide Estimate of Duration and Progression of Pancreatic Cancer Before Diagnosis

Thomas C. Smyrk
2018-05-29

Detection of Gastric Cancer with Novel Methylated DNA Markers: Discovery, Tissue Validation, and Pilot Testing in Plasma

David A. Ahlquist, Thomas C. Smyrk
2018-06-12

Highly Discriminant Methylated DNA Markers for the Non-endoscopic Detection of Barrett's Esophagus

David A. Ahlquist, Thomas C. Smyrk
2018-07-02

A Tale of Three Tails and a Cystic Lesion: A Rare Cause of Recurrent Acute Pancreatitis

Thomas C. Smyrk
2018-08-27

Identification of Prognostic Phenotypes of Esophageal Adenocarcinoma in 2 Independent Cohorts

Sarah A Killcoyne, Yi Qin, Moritz Gerstung, David A. Ahlquist, Thomas C. Smyrk
2018-02-16

Molecular characterization of colorectal adenomas with and without malignancy reveals distinguishing genome, transcriptome and methylome alterations.

Taejeong Bae, Hang Xu, Ann L Oberg, Alexej Abyzov, Lisa A Boardman, David A. Ahlquist, Thomas C. Smyrk, Donna Felmlee-Devine, Jill Washechek-Aletto, Nikolaos Vasmatzis

Human - wd:Q64371564

Welcome to Inventaire

the library of your friends and communities

learn more